Report for Beshore DC

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells - Moore_2022_ACS.Chem.Biol_17_2595
Author(s) : Moore KP , Schwaid AG , Tudor M , Park S , Beshore DC , Converso A , Shipe WD , Anand R , Lan P , Moningka R , Rothman DM , Sun W , Chi A , Cornella-Taracido I , Adam GC , Bahnck-Teets C , Carroll SS , Fay JF , Goh SL , Lusen J , Quan S , Rodriguez S , Xu M , Andrews CL , Song C , Filzen T , Li J , Hollenstein K , Klein DJ , Lammens A , Lim UM , Fang Z , McHale C , Li Y , Lu M , Diamond TL , Howell BJ , Zuck P , Balibar CJ
Ref : ACS Chemical Biology , 17 :2595 , 2022
Abstract : Moore_2022_ACS.Chem.Biol_17_2595
ESTHER : Moore_2022_ACS.Chem.Biol_17_2595
PubMedSearch : Moore_2022_ACS.Chem.Biol_17_2595
PubMedID: 36044633
Gene_locus related to this paper: human-DPP8 , human-DPP9

Title : Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622 - Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
Author(s) : Uslaner JM , Kuduk SD , Wittmann M , Lange HS , Fox SV , Min C , Pajkovic N , Harris D , Cilissen C , Mahon C , Mostoller K , Warrington S , Beshore DC
Ref : Journal of Pharmacology & Experimental Therapeutics , 365 :556 , 2018
Abstract : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
ESTHER : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
PubMedSearch : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556
PubMedID: 29563325